Compare GSK plc (GSK) vs Roundhill S&P 500 0DTE Covered Call Strategy ETF (XDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? GSK plc trades at $50.27 (market cap $102.60B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.48. The key difference: GSK plc pays a 3.57% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and GSK plc is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| GSK | XDTE | |
|---|---|---|
Market Cap | $102.60B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $61.18 | $44.76 |
52-Week Low | $38.22 | $36.00 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
XDTE trades at $39.48, up 0.03% with a bullish technical signal from moving averages, though RSI indicates potential overbought conditions. The ETF focuses on weekly income via covered calls on the S&P 500, with recent dividends averaging around $0.15 per week. Financial ratios are not disclosed, and news highlights high yield claims but questions sustainability.
Outlook hinges on income strategy appeal amid market stability; opportunities include consistent payouts, but risks involve NAV erosion and fee drag. Investor caution is warranted due to mixed sentiment and reliance on options premiums.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Roundhill S&P 500 0DTE Covered Call Strategy ETF
XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →
